Date: 2015-01-05
Type of information: Nomination
Compound:
Company: Silence Therapeutics (UK)
Therapeutic area:
Type agreement: nomination
Action mechanism:
Disease:
Details: * On January 5, 2015, Silence Therapeutics announced that Simon Sturge and Alastair Riddell will exchange roles. As from the 5th January 2015 Alastair Riddell will take on the role of Non-executive Chairman of the Board and Chair the Nominations Committee. Simon Sturge will remain a Non Executive Director and Chair the Remuneration Committee.
Simon Sturge became Non-executive Chairman in November 2013. In March 2014 he was appointed to a senior executive role with Merck KGaA based in Switzerland heading their Biosimilars activity, which has necessarily reduced his availability in UK.
Financial terms:
Latest news:
